Replies to post #90626 on Biotech Values

[flatlander_60048]

That helps me think that NVS was in a fairly knowledgable position when they made the decision not to license IDX 184. The link indicated that it could be used in combination with the SOC.

Is Debio likely to be amenable to use as a combination oral drug?

Thanks

FL